Evidence map›Paper›PMID 17586838›Full record

ArticleJournal of medical genetics2007

The C20orf133 gene is disrupted in a patient with Kabuki syndrome.

Nicole M C Maas, Tom Van de Putte, Cindy Melotte, Annick Francis, Constance T R M Schrander-Stumpel, Damien Sanlaville, David Genevieve, Stanislas Lyonnet, Boyan Dimitrov, Koenraad Devriendt and 2 more

Open access · bronzeAbstract readCase ReportsComparative Study
In one paragraph

Article in Journal of medical genetics, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Peripheral Expression ofPsychiatry and clinical psychopharmacology · 2021
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. The clinical utility of molecular karyotyping for neurocognitive phenotypes in a consanguineous population.Genetics in medicine : official journal of the American College of Medical Genetics · 2015
    Article
  12. Macro domains as metabolite sensors on chromatin.Cellular and molecular life sciences : CMLS · 2013
    Review
  13. Article
  14. Article
  15. The causality of de novo copy number variants is overestimated.European journal of human genetics : EJHG · 2011
    Article
  16. Article
  17. Article
  18. Article
  19. [Tapetoretinal dystrophy and unusual facial features in an 8-year-old boy].Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2010
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Nicole M C MaasCentre for Human Genetics, University of Leuven, Leuven, Belgium.
Tom Van de Putte
Cindy Melotte
Annick Francis
Constance T R M Schrander-Stumpel
Damien Sanlaville
David Genevieve
Stanislas Lyonnet
Boyan Dimitrov
Koenraad Devriendt
Jean-Pierre Fryns
Joris R Vermeesch
KU Leuven · BEAssistance Publique – Hôpitaux de Paris · FRVIB-KU Leuven Center for Cancer Biology · BEMaastricht University Medical Centre · NL

Funding

Wellcome Trust
6 · The paper itself

Abstract

backgroundKabuki syndrome (KS) is a rare, clinically recognisable, congenital mental retardation syndrome. The aetiology of KS remains unknown.

methodsFour carefully selected patients with KS were screened for chromosomal imbalances using array comparative genomic hybridisation at 1 Mb resolution.

resultsIn one patient, a 250 kb de novo microdeletion at 20p12.1 was detected, deleting exon 5 of C20orf133. The function of this gene is unknown. In situ hybridisation with the mouse orthologue of C20orf133 showed expression mainly in brain, but also in kidney, eye, inner ear, ganglia of the peripheral nervous system and lung.

conclusionThe de novo nature of the deletion, the expression data and the fact that C20orf133 carries a macro domain, suggesting a role for the gene in chromatin biology, make the gene a likely candidate to cause the phenotype in this patient with KS. Both the finding of different of chromosomal rearrangements in patients with KS features and the absence of C20orf133 mutations in 19 additional patients with KS suggest that KS is genetically heterogeneous.

Indexed as

Abnormalities, MultipleAmino Acid SequenceAnimalsChromosomes, Human, Pair 20DNA Repair EnzymesExonsFaceFemaleGene Expression Regulation, DevelopmentalHumansHydrolasesInfant, NewbornIntellectual DisabilityMembrane GlycoproteinsMembrane ProteinsMiceDNA Repair EnzymesFLRT3 protein, humanHydrolasesMACROD2 protein, humanMacrod2 protein, mouseMembrane GlycoproteinsMembrane ProteinsTranscription Factors

Identifiers

PMID17586838
PMCPMC2597955
OpenAlexW2119213014

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.